Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Lee & Company
WARNING LETTER
•Lee & Company•February 21, 2013

Lee & Company – FDA Warning Letter, Feb 21, 2013

Record Details

An FDA inspection of Sunnymede Pharmacy, Inc. (dba Lee and Company and Lee Pharmacy) from February 19-21, 2013, revealed significant violations. The firm was producing drug products without valid prescriptions for individually-identified patients, which means these drugs are not exempt under FDCA section 503A and are considered unapproved new drugs and misbranded.

Furthermore, the inspection found serious deficiencies in sterile drug product manufacturing practices, rendering these products adulterated. Specific issues included failure to demonstrate adequate protection of ISO 5 areas, lack of written procedures to prevent microbiological contamination, inadequate environmental monitoring in aseptic processing areas, and insufficient stability testing programs to determine expiration dates. These constitute significant Current Good Manufacturing Practice (CGMP) violations.

The FDA cited violations of FDCA sections 505(a) (unapproved new drugs), 502(f)(1) (misbranded drugs due to inadequate directions for use), 501(a)(2)(A) (adulterated due to insanitary conditions), and 501(a)(2)(B) (adulterated due to CGMP violations). The firm's March 14, 2013, response to the FDA Form 483 was deemed insufficient, as it referenced USP-NF General Chapter <797> compliance but did not address the CGMP requirements for drugs produced without patient-specific prescriptions.

Company
Lee & Company
Inspection date
February 21, 2013
Product type
Drugs
Office
Dallas District Office
People
  • Rose Ashley
  • Reynaldo Rodriguez (District Director)
View Company Profile

ID · f602ac13-123f-4914-afff-756caee68f59

Violation Codes10
21 U.S.C. 353a21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 351(a)(2)(A)21 U.S.C. 331(d)21 U.S.C. 331(k)21 CFR 211.113(b)21 CFR 211.42(c)(10)(iv)21 CFR 211.166(a)21 CFR 210

Full citation text and observation details available on the Dashboard.

Other documents for Lee & Company
  • 483 - 2013-02-21February 21, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lee & Company
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.